- $2.81bn
- $2.37bn
- $1.74bn
- 80
- 30
- 80
- 68
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 79.81 | ||
| PEG Ratio (f) | 2.28 | ||
| EPS Growth (f) | 53.69% | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 4.43 | ||
| Price to Tang. Book | 7.32 | ||
| Price to Free Cashflow | 25.72 | ||
| Price to Sales | 1.62 | ||
| EV to EBITDA | 97.5 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 2.47% | ||
| Return on Equity | 2.4% | ||
| Operating Margin | 0.98% | ||
Financial Summary
| Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | 817.08 | 966.22 | 1,356.66 | 1,657.74 | 1,736.39 | 3,217.84 | 3,554.35 | 17.17% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | +278.97 | n/a | n/a | n/a | -30.43 | +54.76 | +52.21 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Privia Health Group, Inc. is a technology-driven, national physician-enablement company. The Company collaborates with medical groups, health plans and health systems. It enhances physician practices, improves patient experiences and doctors for delivering care in both in-person and virtual care settings. Its Privia Platform is powered by the Privia Technology Solution, an end-to-end, cloud-based technology solution that integrates both Privia-developed and third-party applications into an interface and workflow that manages all aspects of its Privia Providers provision of healthcare services. Privia Platform optimizes provider workflow across the full continuum of reimbursement arrangements. The Company provides management services to each Medical Group though a local management services organization, which provides Medical Groups with access to value-based care (VBC) opportunities either directly or through Privia-owned accountable care organizations.
Directors
- Parth Mehrotra PRE (42)
- Shawn Morris CEO (57)
- David Mountcastle CFO (51)
- Thomas Bartrum EVP (54)
- Jeff Butler DRC (49)
- Jeffrey Bernstein IND (34)
- Will Sherrill IND (32)
- Bill Sullivan IND (57)
- Last Annual
- December 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- August 10th, 2016
- Public Since
- April 29th, 2021
- No. of Shareholders
- 17
- No. of Employees
- 1,140
- Sector
- Healthcare Providers & Services
- Industry
- Healthcare
- Exchange
NASDAQ Global Select Market- Shares in Issue
- 121,313,431
- Address
- 950 N. Glebe Rd., Suite 700, ARLINGTON, 22203
- Web
- https://www.priviahealth.com/
- Phone
- +1 5713668850
- Auditors
- PricewaterhouseCoopers LLP
Upcoming Events for PRVA
Q1 2025 Privia Health Group Inc Earnings Release
Privia Health Group Inc Annual Shareholders Meeting
Privia Health Group Inc Annual Shareholders Meeting
Q2 2025 Privia Health Group Inc Earnings Release
Similar to PRVA
Acadia Healthcare
NASDAQ Global Select Market
Addus HomeCare
NASDAQ Global Select Market
Alignment Healthcare
NASDAQ Global Select Market
Amedisys
NASDAQ Global Select Market
Aveanna Healthcare Holdings
NASDAQ Global Select Market
FAQ
What is the Privia Health share price?
As of Today at 22:44 UTC, shares in Privia Health are trading at $23.17. This share price information is delayed by 15 minutes.
How has the Privia Health share price performed this year?
Shares in Privia Health last closed at $23.17 and the price had moved by +28.79% over the past 365 days. In terms of relative price strength the Privia Health share price has outperformed the S&P500 Index by +18.88% over the past year.
What are the analyst and broker recommendations for Privia Health?
The overall consensus recommendation for Privia Health is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreWhat is the Privia Health dividend yield?
Privia Health does not currently pay a dividend.
Does Privia Health pay a dividend?
Privia Health does not currently pay a dividend.
When does Privia Health next pay dividends?
Privia Health does not currently pay a dividend.
How do I buy Privia Health shares?
To buy shares in Privia Health you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Privia Health?
As of the previous close price of $23.17, shares in Privia Health had a market capitalisation of $2.81bn.
Where are Privia Health shares listed?
Here are the trading details for Privia Health:
- Country of listing: United States
- Exchange: NSQ
- Ticker Symbol: PRVA
What kind of share is Privia Health?
Based on an overall assessment of its quality, value and momentum Privia Health is currently classified as a High Flyer. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Privia Health share price forecast for 2025?
The analyst consensus target price for shares in Privia Health is $29.60. That is 27.75% above the last closing price of $23.17.
Analysts covering Privia Health currently have a consensus Earnings Per Share (EPS) forecast of $0.25 for the next financial year.
Find out moreWhat is the trend in the Privia Health share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Privia Health. Over the past six months, its share price has outperformed the S&P500 Index by +38.36%.
As of the last closing price of $23.17, shares in Privia Health were trading +10.45% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Privia Health PE Ratio?
The Privia Health PE ratio based on its reported earnings over the past 12 months is 79.81. The shares last closed at $23.17.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Privia Health?
Privia Health's management team is headed by:
- Parth Mehrotra - PRE
- Shawn Morris - CEO
- David Mountcastle - CFO
- Thomas Bartrum - EVP
- Jeff Butler - DRC
- Jeffrey Bernstein - IND
- Will Sherrill - IND
- Bill Sullivan - IND